272 related articles for article (PubMed ID: 31713476)
21. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
22. Comparative Evaluation of Safety and Efficacy of Glimepiride and Sitagliptin in Combination with Metformin in Patients with Type 2 Diabetes Mellitus: Indian Multicentric Randomized Trial - START Study.
Devarajan TV; Venkataraman S; Kandasamy N; Oomman A; Boorugu HK; Karuppiah SKP; Balat D
Indian J Endocrinol Metab; 2017; 21(5):745-750. PubMed ID: 28989886
[TBL] [Abstract][Full Text] [Related]
23. Sitagliptin 100 mg vs glimepiride 1-3 mg as an add-on to insulin and metformin in type 2 diabetes (SWIM).
Kesavadev J; Pillai PBS; Shankar A; Krishnan G; Jothydev S
Endocr Connect; 2017 Nov; 6(8):748-757. PubMed ID: 28982699
[TBL] [Abstract][Full Text] [Related]
24. Effect of hydroxychloroquine on beta cell function, insulin resistance, and inflammatory markers in type 2 diabetes patients uncontrolled on glimepiride and metformin therapy.
Rajput R; Upadhyay P; Rajput S; Saini S; Kharab S
Int J Diabetes Dev Ctries; 2023 Feb; ():1-6. PubMed ID: 36777472
[TBL] [Abstract][Full Text] [Related]
25. Teneligliptin Real-World Effectiveness Assessment in Patients with Type 2 Diabetes Mellitus in India: A Retrospective Analysis (TREAT-INDIA 2).
Ghosh S; Tiwaskar M; Chawla R; Jaggi S; Asirvatham A; Panikar V
Diabetes Ther; 2020 Oct; 11(10):2257-2268. PubMed ID: 32779100
[TBL] [Abstract][Full Text] [Related]
26. The Real DAPSI: A Real-World Retrospective Study on Assessing the Efficacy and Safety of a Fixed-Dose Combination of Dapagliflozin and Sitagliptin in the Indian Population.
Bhattacharjee R; Rai M; Joshi P; Prasad A; Birla A
Cureus; 2023 Oct; 15(10):e46767. PubMed ID: 37954782
[TBL] [Abstract][Full Text] [Related]
27. Liraglutide Versus SGLT-2 Inhibitors in People with Type 2 Diabetes: A Network Meta-Analysis.
Lorenzi M; Ploug UJ; Langer J; Skovgaard R; Zoratti M; Jansen J
Diabetes Ther; 2017 Feb; 8(1):85-99. PubMed ID: 27995594
[TBL] [Abstract][Full Text] [Related]
28. Retrospective Observational Study on Assessing Sitagliptin and Dapagliflozin as a Fixed-Dose Combination in the Indian Population With Type 2 Diabetes Mellitus: The SIDAXA Study.
Chawla M; Panneerselvam D; Gundgurthy A; Sud S; Alamchandani R; Aneja P; Nair R; Korukonda KR
Cureus; 2024 May; 16(5):e60815. PubMed ID: 38910691
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Combined Tofogliflozin and Glargine, Tofogliflozin Added to Insulin, and Insulin Dose-Increase Therapy in Uncontrolled Type 2 Diabetes.
Suzuki K; Mitsuma Y; Sato T; Anraku T; Hatta M
J Clin Med Res; 2016 Nov; 8(11):805-814. PubMed ID: 27738482
[TBL] [Abstract][Full Text] [Related]
30. Comparative evaluation of biphasic insulin with metformin and triple oral hypoglycemic agents (OHA) in type 2 diabetes patients.
Alavudeen SS; Khobrani M; Dhanapal CK; Mir JI; Alshahrani SM; Khan NA; Alhossan A
Saudi Pharm J; 2020 Feb; 28(2):210-214. PubMed ID: 32042260
[TBL] [Abstract][Full Text] [Related]
31. ANALYSIS OF ANTIDIABETIC THERAPY FOR TYPE 2 DIABETES IN PRIMARY HEALTH CARE (WESTERN KAZAKHSTAN).
Bazargaliyev Y; Tleumagamabetova B; Kudabayeva K; Kosmuratova R
Georgian Med News; 2024 Mar; (348):22-27. PubMed ID: 38807384
[TBL] [Abstract][Full Text] [Related]
32. An observational study of glycemic control in canagliflozin treated patients.
Meckley LM; Miyasato G; Kokkotos F; Bumbaugh J; Bailey RA
Curr Med Res Opin; 2015 Aug; 31(8):1479-86. PubMed ID: 25986535
[TBL] [Abstract][Full Text] [Related]
33. Effects of Insulin Therapy and Oral Hypoglycemic Agents on Glycemic Control for Type 2 Diabetes Mellitus Patients in China-A Case Control Study.
Zuo P; Shi J; Yan J; Yang L; Liu C; Yuan L; Lou Q
Exp Clin Endocrinol Diabetes; 2021 May; 129(5):374-378. PubMed ID: 30959531
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and Safety of IDegAsp in a Real-World Korean Population with Type 2 Diabetes Mellitus.
Kang S; Ahn YB; Oh TK; Lee WY; Chun SW; Bae B; Dahaoui A; Jeong JS; Jung S; Jang HC
Diabetes Metab J; 2024 Feb; ():. PubMed ID: 38410023
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of the Lilly Connected Care Program in Improving Glycemic Management Among Patients With Type 2 Diabetes in China: Retrospective Real-world Study.
Su B; Chen Y; Shen X; Guo J; Ding Y; Ma X; Yang Y; Liu D
J Med Internet Res; 2023 Apr; 25():e38680. PubMed ID: 37097724
[TBL] [Abstract][Full Text] [Related]
36. Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia.
Sendekie AK; Teshale AB; Tefera YG
PLoS One; 2022; 17(5):e0268639. PubMed ID: 35617250
[TBL] [Abstract][Full Text] [Related]
37. Medium-Term Effect of Add-On Therapy with the DPP-4 Inhibitor, Sitagliptin, in Insulin-Treated Japanese Patients with Type 2 Diabetes Mellitus.
Katsuno T; Ikeda H; Namba M
Diabetes Ther; 2016 Jun; 7(2):309-20. PubMed ID: 27114254
[TBL] [Abstract][Full Text] [Related]
38. Effect of Gliclazide or Gliclazide plus Metformin Combination on Glycemic Control in Patients with T2DM in India: A Real-World, Retrospective, Longitudinal, Observational Study from Electronic Medical Records.
Polavarapu NK; Kale R; Sethi B; Sahay RK; Phadke U; Ramakrishnan S; Mane A; Mehta S; Shah S
Drugs Real World Outcomes; 2020 Dec; 7(4):271-279. PubMed ID: 32648242
[TBL] [Abstract][Full Text] [Related]
39. Effects of basal and premixed insulin on glycemic control in type 2 diabetes patients based on multicenter prospective real-world data.
Peng Y; Xu P; Shi J; Zhang Y; Wang S; Zheng Q; Wang Y; Ke T; Li L; Zhao D; Dai Y; Dong Q; Ji B; Xu F; Gu W; Wang W
J Diabetes; 2022 Feb; 14(2):134-143. PubMed ID: 35023626
[TBL] [Abstract][Full Text] [Related]
40. Teneligliptin real-world efficacy assessment of type 2 diabetes mellitus patients in India (TREAT-INDIA study).
Ghosh S; Trivedi S; Sanyal D; Modi KD; Kharb S
Diabetes Metab Syndr Obes; 2016; 9():347-353. PubMed ID: 27877058
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
